Workspace / Investment packs/healthcare
Prices to 15 Sept 2026 · Financials to 30 Jun 2026 · Developments 14 Sept 2026
Investment pack

Pharma & healthcare

Drug makers, contract manufacturers and hospital chains.

₹1L put in on 1 Sept 2023 and left alone until 1 Sept 2026. Whole shares, dividends counted, nothing rebalanced or sold.

Value today
₹1.9 L

from ₹1L

Gain
₹92,762
+92.8% on the whole amount
Compound annual rate
+24.4%

over 3 years

Companies held
11

of the 12 the rule wanted · 1 lost money

₹1L, month by month

11 holdings plus ₹10,857 in cash
2023 · 100202420252026 · 192.8

The line is the whole position — shares at each month-end, plus dividends as they were paid, plus the cash that never got invested. It is indexed to 100 at the start, so the shape is the return.

What the rule could actually do with the money

The part most tools skip
Deployed
89.1%

₹89,143 bought shares. ₹10,857 could not buy a whole share of anything the rule wanted and sat in cash for the whole 3 years.

Return on the money that was invested: +104.1%. The headline above is lower because it counts the idle cash, which is what would really have happened.

Size split · target 50 / 30 / 20
Large cap6 of 649%
Mid cap3 of 429%
Small cap2 of 222%

Within 5 points of target on every band.

Only 3 mid cap companies in this theme had full history for the window, against a target of 4.

Against the whole market
+55.3%

points ahead of the whole-market pack at the same amount over the same window (+37.4%).

Open the whole-market pack →

Where the return came from

Price movement and dividends, kept apart
Price change
₹90,416

What the shares themselves were worth at the end, less what they cost.

Dividends received
₹2,346

11 of 11 holdings paid something across the 3 years. Dividends are counted as cash when paid and are not reinvested, so nothing here compounds.

Income’s share of the gain
3%

Of the ₹92,762 gained, ₹2,346 arrived as dividends rather than as a higher share price.

The two figures add to the gain exactly — every rupee of return is either a price move or a dividend — and the split matters because they do not behave alike: a dividend is money received, a price gain is only realised if it is sold. The share is not a yield, and a smaller share is not a smaller dividend. It shrinks when prices run, because the denominator grows: across this universe income is about a sixth of the one-year gain and about a twentieth of the five-year gain, from much the same dividends. In a window where prices fell, income can be the only part that was positive.

Sign in to see which companies the rule actually held, and what each one did

Guests see a sample. Members get every company, five-year fundamentals, classified developments, a watchlist and the decision journal.

Sign in with Google

Why these sectors

The grouping is a judgement — here is the one that was made

Small by design. Fourteen companies in the universe carry this sector, so a pack of twelve is close to the whole thing — which makes it a study of the sector rather than a selection within it.

Coverage. 14 of 14 companies in this theme had month-end prices at both ends of the window; the rest were left out rather than filled in. Every ranking used a share count the market had already seen at the start of the window.

Target split 6/4/2 companies · equal weight inside each size band · prices are month-end closes from the adjusted series, so share counts are on today’s basis.